The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

ResMed Inc

NYSE: RMD
Last

(U.S.) $57.08

Today's change-0.24 -0.42%
Updated May 22 4:02 PM EDT. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $57.08

Today's change-0.24 -0.42%
Updated May 22 4:02 PM EDT. Delayed by at least 15 minutes.

ResMed Inc down (U.S.)$0.24

ResMed Inc closed lower Friday, dropping (U.S.)$0.24 or 0.42% to (U.S.)$57.08. Over the last five days, shares have gained 1.57%, but are currently unchanged over the last year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $57.27
  • Previous close(U.S.) $57.32
  • High(U.S.) $57.49
  • Low(U.S.) $56.86
  • Bid / Ask-- / --
  • YTD % change+1.82%
  • Volume802,563
  • Average volume (10-day)1,903,463
  • Average volume (1-month)1,454,654
  • Average volume (3-month)1,025,110
  • 52-week range(U.S.) $45.74 to (U.S.) $75.33
  • Beta0.63
  • Trailing P/E23.07×
  • P/E 1 year forward22.41×
  • Forward PEG2.11×
  • Indicated annual dividend(U.S.) $1.12
  • Dividend yield1.96%
  • Trailing EPS(U.S.) $2.47
Updated May 22 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+21.52%

Based on its net profit margin of 21.52%, ResMed Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.07%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue422423380415
Total other revenue--------
Total revenue422423380415
Gross profit251263237261
Total cost of revenue171160143154
Total operating expense317314286317
Selling / general / administrative116123111122
Research & development27293032
Depreciation / amortization2222
Interest expense (income), net operating--------
Unusual expense (income)------6
Other operating expenses, total--------
Operating income1061099598
Interest income (expense), net non-operating-------6
Gain (loss) on sale of assets--------
Other--------
Income before tax114116102107
Income after tax91918388
Income tax, total23241919
Net income91918388
Total adjustments to net income--------
Net income before extra. items91918388
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items91918388
Inc. avail. to common incl. extra. items91918388
Diluted net income91918388
Dilution adjustment--------
Diluted weighted average shares143142143143
Diluted EPS excluding extraordinary itemsvalue per share0.640.640.580.61
Dividends per sharevalue per share0.280.280.280.25
Diluted normalized EPSvalue per share0.640.640.580.65